U.S. federal trademark · Serial No. 79271613 · Reg. No. 6187216
Pharmaceuticals, medical and veterinary preparations for the treatment of cancer, cardiovascular disease, respiratory disorders, metabolic disorders, autoimmune disease, neurologic and psychiatric disorders and infectious disease derived from PEGylation technologies; pharmaceutical preparations, namely, a drug delivery system comprising phosphotriester linkers for the controlled release of a wide variety of therapeutic agents; pharmaceutical, medical and veterinary substances
Scientific and technological services, namely, scientific research, analysis, testing and development in the field of pharmaceuticals, of pharmaceutical, medical and veterinary preparations, reagents and substances, and of diagnostic preparations, reagents and substances derived from PEGylation technologies; PEGylation pharmaceuticals research services
Reagents for scientific and research use, Diagnostic preparations for scientific or research use, namely, reagents for use with a drug delivery system comprising phosphotriester linkers for the controlled release of a wide variety of therapeutic agents; cross linking agents being industrial chemicals for use in industry and science; polyethylene glycols for use in industry and science; chemical structures being industrial chemicals, namely, phosphotriester linkers
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.